Capital Goods Healthcare Sector

Maravai LifeSciences Holdings

Market Cap: US$552.6m

A life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America.

Elite Pharmaceuticals

Market Cap: US$551.7m

A specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals.

Advanced Medical Solutions Group

Market Cap: UK£411.6m

Develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally.

Akso Health Group

Market Cap: US$545.9m

Operates a social e-commerce mobile platform in the People’s Republic of China.

Regulus Therapeutics

Market Cap: US$544.9m

A clinical-stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States.

Owens & Minor

Market Cap: US$543.2m

Operates as a healthcare solutions company worldwide.

Kura Oncology

Market Cap: US$540.2m

A clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer.

Enhabit

Market Cap: US$539.3m

Provides home health and hospice services in the United States.

Stoke Therapeutics

Market Cap: US$536.7m

An early-stage biopharmaceutical company, engages in the development of treatments for severe genetic diseases by upregulating protein expression.

Axogen

Market Cap: US$535.6m

Develops and commercializes technologies for peripheral nerve regeneration and repair worldwide.

Mind Medicine (MindMed)

Market Cap: US$529.6m

A clinical stage biopharmaceutical company, develops novel products to treat brain health disorders.

Auna

Market Cap: US$523.7m

A healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia.

Tyra Biosciences

Market Cap: US$514.8m

A clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States.

Eton Pharmaceuticals

Market Cap: US$507.7m

A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.

Talkspace

Market Cap: US$503.6m

Operates as a virtual behavioral healthcare company that connects patients with licensed mental health providers in the United States.

Healius

Market Cap: AU$769.7m

Provides specialty diagnostic services to consumer and practitioners in Australia.

REGENXBIO

Market Cap: US$491.1m

A clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States.

LifeMD

Market Cap: US$487.2m

Operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States.

Zevra Therapeutics

Market Cap: US$487.2m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

Upstream Bio

Market Cap: US$486.8m

A clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders.

Virtus Health

Market Cap: AU$705.2m

Virtus Health Limited provides various healthcare services in Australia, Denmark, the United Kingdom, Ireland, and Singapore.

Castle Biosciences

Market Cap: US$483.6m

A molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett’s esophagus (BE), uveal melanoma, and mental health conditions.

Semler Scientific

Market Cap: US$482.5m

Provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States.

Relay Therapeutics

Market Cap: US$481.8m

Operates as a clinical-stage precision medicines company.

Definitive Healthcare

Market Cap: US$481.5m

Provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally.

CytoDyn

Market Cap: US$481.4m

A clinical-stage biotechnology company, engages in the development of treatments for multiple therapeutic indications.

Amylyx Pharmaceuticals

Market Cap: US$477.8m

A clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States.

Opthea

Market Cap: AU$738.8m

A clinical-stage biopharmaceutical company, develops and commercializes drugs for eye diseases in Australia and the United States.

Arvinas

Market Cap: US$476.6m

A clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins.

Botanix Pharmaceuticals

Market Cap: AU$742.5m

Engages in the research and development of dermatology and antimicrobial products in Australia and the United States.

Capricor Therapeutics

Market Cap: US$474.0m

A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.

Orthofix Medical

Market Cap: US$472.5m

Operates as a medical technology company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally.

Clarity Pharmaceuticals

Market Cap: AU$735.9m

A clinical stage radiopharmaceutical company, engages in research and development and clinical stage radiopharmaceuticals products in Australia and the United States.

Sonida Senior Living

Market Cap: US$468.4m

Owns and operates senior housing communities in the United States.

Zenas BioPharma

Market Cap: US$460.6m

A clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies.

Theravance Biopharma

Market Cap: US$460.0m

A biopharmaceutical company, develops and commercializes of medicines in the United States.